NDC52544-0848-28
|
norgestrel and ethi
|
Watson Pharmaceuticals Inc
|
6505-01-519-3350 |
Avl
|
RFQ
|
NDC52544-0248-28
|
norethindrone and e
|
Watson Pharmaceuticals Inc
|
6505-01-506-2599 |
Avl
|
RFQ
|
NDC52544-0044-24
|
flurandrenolide tap
|
Watson Pharmaceuticals Inc
|
6505-01-153-3883 |
Avl
|
RFQ
|
NDC52544 0936 28
|
norethindrone and e
|
Watson Pharmaceuticals Inc
|
6505-01-506-2659 |
Avl
|
RFQ
|
NDC52544 0472 08
|
estradiol transdermal system
|
Watson Pharmaceuticals Inc
|
6505-01-509-2195 |
Avl
|
RFQ
|
NDC52544 0275 36
|
levonorgestrel tablets
|
Watson Pharmaceuticals Inc
|
6505-01-524-9195 |
Avl
|
RFQ
|
NDC52544 0044 80
|
flurandrenolide tap
|
Watson Pharmaceuticals Inc
|
6505-00-168-6813 |
Avl
|
RFQ
|
NDC16252-0592-99
|
sumatriptan succina
|
Watson Pharmaceuticals Inc
|
6505-01-531-9924 |
Avl
|
RFQ
|
NDC16252-0524-01
|
acarbose tablets
|
Watson Pharmaceuticals Inc
|
6505-01-434-0937 |
Avl
|
RFQ
|
NDC16252-0514-01
|
ciprofloxacin table
|
Watson Pharmaceuticals Inc
|
6505-01-333-4155 |
Avl
|
RFQ
|
NDC00591-5882-01
|
methylphenidate hyd
|
Watson Pharmaceuticals Inc
|
6505-00-584-3174 |
Avl
|
RFQ
|
NDC00591-5694-01
|
minocycline hydroch
|
Watson Pharmaceuticals Inc
|
6505-01-015-4147 |
Avl
|
RFQ
|
NDC00591-5347-01
|
probenecid tablets
|
Watson Pharmaceuticals Inc
|
6505-00-527-6885 |
Avl
|
RFQ
|
NDC00591-5307-01
|
promethazine hydroc
|
Watson Pharmaceuticals Inc
|
6505-01-364-8557 |
Avl
|
RFQ
|
NDC00591-2715-01
|
methylphenidate hyd
|
Watson Pharmaceuticals Inc
|
6505-01-486-0173 |
Avl
|
RFQ
|
NDC00591-0810-46
|
sulfadiazine silver
|
Watson Pharmaceuticals Inc
|
6505-00-560-7331 |
Avl
|
RFQ
|
NDC00591-0787-01
|
chlordiazepoxide hydrochloride capsules usp
|
Watson Pharmaceuticals Inc
|
6505-01-289-9827 |
Avl
|
RFQ
|
NDC00591-0781-30
|
clomiphene citrate
|
Watson Pharmaceuticals Inc
|
6505-00-181-7678 |
Avl
|
RFQ
|
NDC00591-0749-01
|
oxycodone and aceta
|
Watson Pharmaceuticals Inc
|
6505-01-082-5509 |
Avl
|
RFQ
|
NDC00591-0657-01
|
buspirone hydrochloride tablet usp
|
Watson Pharmaceuticals Inc
|
6505-01-253-2832 |
Avl
|
RFQ
|
NDC00591-0444-01
|
guanfacine hydrochl
|
Watson Pharmaceuticals Inc
|
6505-01-276-7978 |
Avl
|
RFQ
|
NDC00591 5778 01
|
atenolol tablets us
|
Watson Pharmaceuticals Inc
|
6505-01-138-4751 |
Avl
|
RFQ
|
NDC00591 5714 01
|
amoxapine tablets u
|
Watson Pharmaceuticals Inc
|
6505-01-111-3195 |
Avl
|
RFQ
|
NDC00591 5695 50
|
minocycline hydroch
|
Watson Pharmaceuticals Inc
|
6505-00-003-5112 |
Avl
|
RFQ
|
NDC00591 5660 05
|
sulindac tablets usp
|
Watson Pharmaceuticals Inc
|
6505-01-325-0112 |
Avl
|
RFQ
|
NDC00591 5553 50
|
doxycycline hyclate
|
Watson Pharmaceuticals Inc
|
6505-01-095-4175 |
Avl
|
RFQ
|
NDC00591 5544 05
|
allopurinol tablets
|
Watson Pharmaceuticals Inc
|
6505-01-090-9251 |
Avl
|
RFQ
|
NDC00591 5443 10
|
prednisone tablets usp
|
Watson Pharmaceuticals Inc
|
6505-01-220-5067 |
Avl
|
RFQ
|
NDC00591 2520 01
|
chlorzoxazone table
|
Watson Pharmaceuticals Inc
|
6505-01-264-4453 |
Avl
|
RFQ
|
NDC00591 2468 01
|
metoclopramide tabl
|
Watson Pharmaceuticals Inc
|
6505-01-130-9358 |
Avl
|
RFQ
|
NDC00591 2234 01
|
tetracycline hydroc
|
Watson Pharmaceuticals Inc
|
6505-00-655-8355 |
Avl
|
RFQ
|
NDC00591 2190 45
|
neomycin and polymy
|
Watson Pharmaceuticals Inc
|
6505-01-224-6361 |
Avl
|
RFQ
|
NDC00591 0820 01
|
oxycodone and aspirin tablets usp
|
Watson Pharmaceuticals Inc
|
6505-01-030-9493 |
Avl
|
RFQ
|
NDC00591 0796 05
|
sulfasalazine table
|
Watson Pharmaceuticals Inc
|
6505-00-754-2797 |
Avl
|
RFQ
|
NDC00591 0780 05
|
sucralfate tablets
|
Watson Pharmaceuticals Inc
|
6505-01-322-6499 |
Avl
|
RFQ
|
NDC00591 0606 01
|
labetalol hydrochlo
|
Watson Pharmaceuticals Inc
|
6505-01-209-1212 |
Avl
|
RFQ
|
NDC00591 0462 10
|
metoprolol tartrate
|
Watson Pharmaceuticals Inc
|
6505-01-071-6557 |
Avl
|
RFQ
|
NDC00591 0387 01
|
hydrocodone bitartrate and acetaminophen tablets u
|
Watson Pharmaceuticals Inc
|
6505-01-503-8935 |
Avl
|
RFQ
|
NDC00536-7415-51
|
sodium phosphates e
|
Watson Pharmaceuticals Inc
|
6505-00-619-8215 |
Avl
|
RFQ
|
NDC00536-4408-01
|
pyridoxine hydrochl
|
Watson Pharmaceuticals Inc
|
6505-00-138-4995 |
Avl
|
RFQ
|
NDC00536-4106-02
|
calcium carbonate t
|
Watson Pharmaceuticals Inc
|
6505-01-350-1091 |
Avl
|
RFQ
|
NDC00536-3467-10
|
chlorpheniramine ma
|
Watson Pharmaceuticals Inc
|
6505-00-299-8610 |
Avl
|
RFQ
|
NDC00536-3313-10
|
aspirin delayed rel
|
Watson Pharmaceuticals Inc
|
6505-00-063-5631 |
Avl
|
RFQ
|
NDC00536-3106-23
|
nicotine polacrilex
|
Watson Pharmaceuticals Inc
|
6505-01-481-3146 |
Avl
|
RFQ
|
NDC00536-0940-94
|
tetrahydrozoline hy
|
Watson Pharmaceuticals Inc
|
6505-00-139-4600 |
Avl
|
RFQ
|
NDC00536-0650-85
|
ferrous sulfate elixir
|
Watson Pharmaceuticals Inc
|
6505-01-539-3554 |
Avl
|
RFQ
|
NDC00536 7502 25
|
desonide ointment
|
Watson Pharmaceuticals Inc
|
6505-01-140-1633 |
Avl
|
RFQ
|
NDC00536 5904 01
|
senna concentrate s
|
Watson Pharmaceuticals Inc
|
6505-00-656-1468 |
Avl
|
RFQ
|
NDC00536 5150 26
|
tolnaftate powder u
|
Watson Pharmaceuticals Inc
|
6505-01-480-7897 |
Avl
|
RFQ
|
NDC00536 4089 56
|
benzoyl peroxide ge
|
Watson Pharmaceuticals Inc
|
6505-01-147-9554 |
Avl
|
RFQ
|